XML 96 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Marketable Securities - Summary of Amortized Cost Gross Unrealized Holding Gains or Losses, and Fair Value of Marketable Securities - Graphite Bio, Inc. (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]    
Gross Unrealized Gains $ 11  
Unrealized Losses (3)  
Total marketable securities measured at fair value 30,654  
Graphite Bio, Inc.    
Schedule Of Available For Sale Securities [Line Items]    
Debt Securities, Available-for-Sale, Amortized Cost   $ 236,869
Gross Unrealized Gains   28
Unrealized Losses   (1,076)
Total marketable securities measured at fair value   235,821
U.S. treasury securities    
Schedule Of Available For Sale Securities [Line Items]    
Gross Unrealized Gains 1  
Unrealized Losses 0  
Total marketable securities measured at fair value 1,978  
U.S. treasury securities | Graphite Bio, Inc.    
Schedule Of Available For Sale Securities [Line Items]    
Debt Securities, Available-for-Sale, Amortized Cost   65,807
Gross Unrealized Gains   0
Unrealized Losses   (416)
Total marketable securities measured at fair value   65,391
Commercial paper    
Schedule Of Available For Sale Securities [Line Items]    
Gross Unrealized Gains 9  
Unrealized Losses 0  
Total marketable securities measured at fair value $ 18,751  
Commercial paper | Graphite Bio, Inc.    
Schedule Of Available For Sale Securities [Line Items]    
Debt Securities, Available-for-Sale, Amortized Cost   115,381
Gross Unrealized Gains   13
Unrealized Losses   (333)
Total marketable securities measured at fair value   115,061
Asset Backed Securities | Graphite Bio, Inc.    
Schedule Of Available For Sale Securities [Line Items]    
Debt Securities, Available-for-Sale, Amortized Cost   1,914
Gross Unrealized Gains   0
Unrealized Losses   0
Total marketable securities measured at fair value   1,914
U.S. agency securities | Graphite Bio, Inc.    
Schedule Of Available For Sale Securities [Line Items]    
Debt Securities, Available-for-Sale, Amortized Cost   53,767
Gross Unrealized Gains   15
Unrealized Losses   (327)
Total marketable securities measured at fair value   $ 53,455